Altered tumor antigen peptide vaccines and their application in oncotherapy / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 417-420, 2008.
Article
Dans Chinois
| WPRIM
| ID: wpr-399954
ABSTRACT
Tumor antigenic peptide vaccines,which have been adapted with altered peptide ligand (APL) and adjuvant to improve cytotoxic T lymphocyte response,include vaccines of different originations. These vaccines are orginated from malignant melanoma differentiation, HER2, NY- ESO-1, carcinoembryonic antigen and etc. Recently,great advances have been made in the related alteration methods,peptide designing principles and cytotoxic T lymphocyte response improvement mechanisms of these peptide vaccines. Furthermore,the vac- cines are showing satisfying pedormances in clinical treatments.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Journal of International Oncology
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS